Publications 2003

 

Levy Y, Durier C, Krzysiek R, Rabian C, Capitant C, Lascaux AS, Michon C, Oksenhendler E, Weiss L, Gastaut JA, Goujard C, Rouzioux C, Maral J, Delfraissy JF, Emilie D, Aboulker JP and the ANRS 079 study group. Effects of Interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomised controlled trial. AIDS 2003, 17 : 343-351.Lien PubMed

Litalien C, Faye A, Compagnucci A, Giaquinto C, Harper L, Gibb DM, Jacqz-Aigrain E.Pharmacokinetics of Nelfinavir ant its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
Pediatr Infect Dis J 2003, 22 : 48-55. Lien PubMed

Diagbouga S, Chazallon C, Kazatchkine M, Van de Perre P, Inwoley A, M’Boup S, Prince David M, Ténin Aoua Thiéro, Soudré R, Aboulker JP, Weiss L.Successful implementation of a low cost method for enumerating CD4+ T lymphocytes in resource-limited settings (ANRS 12-26 study).
AIDS 2003, 17: 2201-2208.Lien PubMed

Lan NT, Recordon-Pinson P, Hung PV, Uyen NT, Lien TT, Tien HT, Garrigue I, Schrive MH, Pellegrin I, Lafon ME, Aboulker JP, Barre-Sinousi F, Fleury HJ. HIV-1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam) : ANRS 1257 study . Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs.
AIDS Res Hum Retroviruses 2003, 19:925-28.Lien PubMed